6C50

Cross-alpha Amyloid-like Structure alphaAmS


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.50 Å
  • R-Value Free: 0.246 
  • R-Value Work: 0.198 
  • R-Value Observed: 0.200 

wwPDB Validation   3D Report Full Report


This is version 1.2 of the entry. See complete history


Literature

Designed peptides that assemble into cross-alpha amyloid-like structures.

Zhang, S.Q.Huang, H.Yang, J.Kratochvil, H.T.Lolicato, M.Liu, Y.Shu, X.Liu, L.DeGrado, W.F.

(2018) Nat Chem Biol 14: 870-875

  • DOI: https://doi.org/10.1038/s41589-018-0105-5
  • Primary Citation of Related Structures:  
    6C4X, 6C4Y, 6C4Z, 6C50, 6C51, 6C52, 6D02, 6O3N

  • PubMed Abstract: 

    Amyloids adopt 'cross-β' structures composed of long, twisted fibrils with β-strands running perpendicular to the fibril axis. Recently, a toxic peptide was proposed to form amyloid-like cross-α structures in solution, with a planar bilayer-like assembly observed in the crystal structure. Here we crystallographically characterize designed peptides that assemble into spiraling cross-α amyloid-like structures, which resemble twisted β-amyloid fibrils. The peptides form helical dimers, stabilized by packing of small and apolar residues, and the dimers further assemble into cross-α amyloid-like fibrils with superhelical pitches ranging from 170 Å to 200 Å. When a small residue that appeared critical for packing was converted to leucine, it resulted in structural rearrangement to a helical polymer. Fluorescently tagged versions of the designed peptides form puncta in mammalian cells, which recover from photobleaching with markedly different kinetics. These structural folds could be potentially useful for directing in vivo protein assemblies with predetermined spacing and stabilities.


  • Organizational Affiliation

    Department of Chemistry, University of Pennsylvania, Philadelphia, PA, USA.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Cross-alpha Amyloid-like Structure alphaAmS
A [auth A1],
AA [auth G3],
AB [auth N1],
AC [auth T3],
AD [auth 11],
AE [auth 73],
AF [auth e1],
AG [auth k3],
AH [auth r1],
AI [auth x3],
B [auth A2],
BA [auth G4],
BB [auth N2],
BC [auth T4],
BD [auth 12],
BE [auth 74],
BF [auth e2],
BG [auth k4],
BH [auth r2],
BI [auth x4],
C [auth A3],
CA [auth H1],
CB [auth N3],
CC [auth U1],
CD [auth 13],
CE [auth 81],
CF [auth e3],
CG [auth l1],
CH [auth r3],
D [auth A4],
DA [auth H2],
DB [auth N4],
DC [auth U2],
DD [auth 14],
DE [auth 82],
DF [auth e4],
DG [auth l2],
DH [auth r4],
E [auth B1],
EA [auth H3],
EB [auth O1],
EC [auth U3],
ED [auth 21],
EE [auth 83],
EF [auth f1],
EG [auth l3],
EH [auth s1],
F [auth B2],
FA [auth H4],
FB [auth O2],
FC [auth U4],
FD [auth 22],
FE [auth 84],
FF [auth f2],
FG [auth l4],
FH [auth s2],
G [auth B3],
GA [auth I1],
GB [auth O3],
GC [auth V1],
GD [auth 23],
GE [auth 91],
GF [auth f3],
GG [auth m1],
GH [auth s3],
H [auth B4],
HA [auth I2],
HB [auth O4],
HC [auth V2],
HD [auth 24],
HE [auth 92],
HF [auth f4],
HG [auth m2],
HH [auth s4],
I [auth C1],
IA [auth I3],
IB [auth P1],
IC [auth V3],
ID [auth 31],
IE [auth 93],
IF [auth g1],
IG [auth m3],
IH [auth t1],
J [auth C2],
JA [auth I4],
JB [auth P2],
JC [auth V4],
JD [auth 32],
JE [auth 94],
JF [auth g2],
JG [auth m4],
JH [auth t2],
K [auth C3],
KA [auth J1],
KB [auth P3],
KC [auth W1],
KD [auth 33],
KE [auth a1],
KF [auth g3],
KG [auth n1],
KH [auth t3],
L [auth C4],
LA [auth J2],
LB [auth P4],
LC [auth W2],
LD [auth 34],
LE [auth a2],
LF [auth g4],
LG [auth n2],
LH [auth t4],
M [auth D1],
MA [auth J3],
MB [auth Q1],
MC [auth W3],
MD [auth 41],
ME [auth a3],
MF [auth h1],
MG [auth n3],
MH [auth u1],
N [auth D2],
NA [auth J4],
NB [auth Q2],
NC [auth W4],
ND [auth 42],
NE [auth a4],
NF [auth h2],
NG [auth n4],
NH [auth u2],
O [auth D3],
OA [auth K1],
OB [auth Q3],
OC [auth X1],
OD [auth 43],
OE [auth b1],
OF [auth h3],
OG [auth o1],
OH [auth u3],
P [auth D4],
PA [auth K2],
PB [auth Q4],
PC [auth X2],
PD [auth 44],
PE [auth b2],
PF [auth h4],
PG [auth o2],
PH [auth u4],
Q [auth E1],
QA [auth K3],
QB [auth R1],
QC [auth X3],
QD [auth 51],
QE [auth b3],
QF [auth i1],
QG [auth o3],
QH [auth v1],
R [auth E2],
RA [auth K4],
RB [auth R2],
RC [auth X4],
RD [auth 52],
RE [auth b4],
RF [auth i2],
RG [auth o4],
RH [auth v2],
S [auth E3],
SA [auth L1],
SB [auth R3],
SC [auth Y1],
SD [auth 53],
SE [auth c1],
SF [auth i3],
SG [auth p1],
SH [auth v3],
T [auth E4],
TA [auth L2],
TB [auth R4],
TC [auth Y2],
TD [auth 54],
TE [auth c2],
TF [auth i4],
TG [auth p2],
TH [auth v4],
U [auth F1],
UA [auth L3],
UB [auth S1],
UC [auth Y3],
UD [auth 61],
UE [auth c3],
UF [auth j1],
UG [auth p3],
UH [auth w1],
V [auth F2],
VA [auth L4],
VB [auth S2],
VC [auth Y4],
VD [auth 62],
VE [auth c4],
VF [auth j2],
VG [auth p4],
VH [auth w2],
W [auth F3],
WA [auth M1],
WB [auth S3],
WC [auth Z1],
WD [auth 63],
WE [auth d1],
WF [auth j3],
WG [auth q1],
WH [auth w3],
X [auth F4],
XA [auth M2],
XB [auth S4],
XC [auth Z2],
XD [auth 64],
XE [auth d2],
XF [auth j4],
XG [auth q2],
XH [auth w4],
Y [auth G1],
YA [auth M3],
YB [auth T1],
YC [auth Z3],
YD [auth 71],
YE [auth d3],
YF [auth k1],
YG [auth q3],
YH [auth x1],
Z [auth G2],
ZA [auth M4],
ZB [auth T2],
ZC [auth Z4],
ZD [auth 72],
ZE [auth d4],
ZF [auth k2],
ZG [auth q4],
ZH [auth x2]
27synthetic constructMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
MPD
Query on MPD

Download Ideal Coordinates CCD File 
LK [auth 74]
MJ [auth R3]
PL [auth q3]
RI [auth G2]
UJ [auth W2]
LK [auth 74],
MJ [auth R3],
PL [auth q3],
RI [auth G2],
UJ [auth W2],
WJ [auth X3]
(4S)-2-METHYL-2,4-PENTANEDIOL
C6 H14 O2
SVTBMSDMJJWYQN-YFKPBYRVSA-N
FMT
Query on FMT

Download Ideal Coordinates CCD File 
AJ [auth L2]
AK [auth Z3]
AL [auth f4]
AM [auth x4]
BJ [auth L3]
AJ [auth L2],
AK [auth Z3],
AL [auth f4],
AM [auth x4],
BJ [auth L3],
BK [auth Z4],
BL [auth g1],
CI [auth A1],
CJ [auth L4],
CK [auth 13],
CL [auth g4],
DI [auth A1],
DJ [auth M2],
DK [auth 14],
DL [auth h2],
EI [auth A3],
EJ [auth N1],
EK [auth 24],
EL [auth i1],
FI [auth A4],
FJ [auth O1],
FK [auth 32],
FL [auth i2],
GI [auth B3],
GJ [auth O2],
GK [auth 42],
GL [auth j1],
HI [auth B4],
HJ [auth O3],
HK [auth 43],
HL [auth j3],
II [auth C2],
IJ [auth P2],
IK [auth 44],
IL [auth k4],
JI [auth D1],
JJ [auth P3],
JK [auth 62],
JL [auth m2],
KI [auth D2],
KJ [auth Q2],
KK [auth 72],
KL [auth m3],
LI [auth E1],
LJ [auth Q3],
LL [auth m4],
MI [auth E3],
MK [auth 81],
ML [auth n2],
NI [auth E4],
NJ [auth R4],
NK [auth 82],
NL [auth o4],
OI [auth F3],
OJ [auth S1],
OK [auth 83],
OL [auth q1],
PI [auth F4],
PJ [auth S2],
PK [auth 92],
QI [auth G2],
QJ [auth T2],
QK [auth 93],
QL [auth r2],
RJ [auth T3],
RK [auth a4],
RL [auth r3],
SI [auth G3],
SJ [auth U1],
SK [auth b1],
SL [auth s2],
TI [auth H1],
TJ [auth U2],
TK [auth b4],
TL [auth t1],
UI [auth H2],
UK [auth c4],
UL [auth t3],
VI [auth H3],
VJ [auth W4],
VK [auth d1],
VL [auth u2],
WI [auth I3],
WK [auth d2],
WL [auth u3],
XI [auth I4],
XJ [auth X4],
XK [auth e1],
XL [auth v3],
YI [auth J2],
YJ [auth Y4],
YK [auth e4],
YL [auth w4],
ZI [auth K2],
ZJ [auth Z1],
ZK [auth e4],
ZL [auth x1]
FORMIC ACID
C H2 O2
BDAGIHXWWSANSR-UHFFFAOYSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.50 Å
  • R-Value Free: 0.246 
  • R-Value Work: 0.198 
  • R-Value Observed: 0.200 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 161.166α = 90
b = 160.159β = 109.97
c = 198.502γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
XDSdata scaling
MOLREPphasing

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)United StatesR35GM122603

Revision History  (Full details and data files)

  • Version 1.0: 2018-08-15
    Type: Initial release
  • Version 1.1: 2018-08-29
    Changes: Data collection, Database references
  • Version 1.2: 2019-12-18
    Changes: Author supporting evidence